StonvexLoading…
StonvexStonvexStonvexCore line items from UGI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $7.15B | $7.04B | $8.76B | $9.98B |
Operating Income | $1.11B | $770.00M | $-1.44B | $1.67B |
Net Income | $678.00M | $269.00M | $-1.50B | $1.07B |
EPS (Diluted) | $3.09 | $1.25 | $-7.16 | $4.97 |
Total Assets | $15.46B | $15.10B | $15.40B | $17.57B |
Total Liabilities | $10.68B | $10.74B | $11.01B | $11.50B |
Cash & Equivalents | $335.00M | $213.00M | $241.00M | $405.00M |
Free Cash Flow OCF − CapEx | $390.00M | $386.00M | $133.00M | $-88.00M |
Shares Outstanding | 219.16M | 215.27M | 209.81M | 215.82M |